Results of a two-year pilot study of clinical outcome measures in collagen VI- and laminin alpha2-related congenital muscular dystrophies
- 1 January 2015
- journal article
- Published by Elsevier in Neuromuscular Disorders
- Vol. 25 (1) , 43-54
Abstract
No abstract availableKeywords
Funding Information
- Cure CMD
- NIH
This publication has 35 references indexed in Scilit:
- Hammersmith Functional Motor Scale and Motor Function Measure-20 in non ambulant SMA patientsNeuromuscular Disorders, 2014
- Development and psychometric properties of the PROMIS® pediatric fatigue item banksQuality of Life Research, 2013
- Clinical and molecular cross-sectional study of a cohort of adult type III spinal muscular atrophy patients: clues from a biomarker studyEuropean Journal of Human Genetics, 2012
- Participation and quality of life in children with Duchenne muscular dystrophy using the international classification of functioning, disability, and healthHealth and Quality of Life Outcomes, 2012
- Development of a Functional Assessment Scale for Ambulatory Boys with Duchenne Muscular DystrophyPhysiotherapy Research International, 2011
- Natural history of Ullrich congenital muscular dystrophyNeurology, 2009
- Reliable surrogate outcome measures in multicenter clinical trials of Duchenne muscular dystrophyMuscle & Nerve, 2006
- Reliability of 4 Outcome Measures in Pediatric Spinal Muscular AtrophyArchives of Neurology, 2003
- Perception of quality of life by patients, partners and treating physiciansQuality of Life Research, 2000
- The Intraclass Correlation Coefficient as a Measure of ReliabilityPsychological Reports, 1966